Factors associated with HIV and hepatitis C infection among regular and non-regular injection drug users in Baltimore by Graham, CM et al.
BioMed  Central
Page 1 of 1
(page number not for citation purposes)
Retrovirology
Open Access Poster presentation
Factors associated with HIV and hepatitis C infection among 
regular and non-regular injection drug users in Baltimore
CM Graham*, SG Severtson, MM Mitchell, L Floyd and WW Latimer
Address: Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, 2120, USA
* Corresponding author    
Background
This study explores the association of length of time
(short or long term) of regular injection drug use, time to
regular injection drug use after first use, and demographic
factors with HIV and hepatitis C (HCV) infection preva-
lence.
Materials and methods
Data on 410 injection drug users (IDU) were from the
International Neurobehavioral HIV Study, an epidemio-
logical examination of neuropsychological, social, and
behavioral risk factors of HIV and hepatitis A, B and C.
Results
Long term IDUs were more likely to be infected with HCV
(OR = 2.61) or HIV (OR = 2.60) compared to short term
injectors. Those who became regular injectors the first
week (OR = 3.44), a week to 6 months (OR = 3.92), or
more than 6 months (OR = 3.00) after first use were more
likely to be infected with HCV than those who never
became regular users. Time to regular injection drug use
was not associated with HIV infection.
Conclusion
Extant studies suggest drug users at HIV risk have an even
greater risk of contracting HCV. Our study findings sug-
gest that identifying injectors who progress from initia-
tion to regular use rapidly are at heightened HCV risk and
may benefit from targeted prevention interventions.
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